Global Hematology Analyzers and Reagents Market Size, Share, Forecast Report, 2020-2027

The global hematology analyzers and reagents market size is expected to reach USD 10.6 billion by 2025 from USD 7.6 billion in 2020, at a CAGR of 6.9%. Market growth is largely driven by factors such as the growth in the number of blood donations, increasing incidence of blood disorders, and technological advancements in hematology analyzers and reagents.
The hematology products & services segment accounted for the largest market share in 2019.
Based on products & services, the hematology analyzers and reagents market is classified into hematology, hemostasis, and immunohematology products & services. The hematology products & services segment accounted for the largest market share in 2019. This can be attributed to the increasing adoption of POC testing hematology analyzers in emerging economies, the launch of technologically advanced hematology products, the increasing preference for automation, and the availability of a wide range of services from major hematology providers.

The low-end hematology analyzers segment accounted for the largest share of the global hematology instruments market, by price range, in 2019.
By price range, the hematology instruments market is classified into high-end, mid-range, and low-end hematology analyzers. The low-end hematology analyzers segment accounted for the largest share of the global hematology instruments market in 2019.

The commercial service providers segment accounted for the largest share of the market, by end user, in 2019.
On the basis of end user, the hematology products & services market is segmented into hospital laboratories, commercial service providers, government reference laboratories, and research & academic institutes. In 2019, the commercial service providers segment accounted for the largest share of the market owing to the increasing incidence of leukemia and anemia, shift from manual testing to automated testing, and the competitive benefits offered by these providers as compared to hospitals (such as affordable service costs, efficient turnaround time, and efficient management for sample collection).
North America commanded the largest share of the market, by region, in 2019.
North America commanded the largest share of the market in 2019, owing to factors such as rising incidence of patients suffering from blood disorders, growing prevalence of target diseases, and rising demand for blood transfusions in the region.

Key Market Players
The major players of the market are Sysmex Corporation (Japan), Danaher Corporation (US), Nihon Kohden (Japan), Siemens (Germany), Abbott (US), Boule Diagnostics (Sweden), HORIBA (Japan), Bio-Rad Laboratories (US), BioSystems (Spain), Diatron (Hungary), Drew Scientific (US), EKF Diagnostics (UK), Mindray (China), Ortho Clinical Diagnostics (US), and Roche (Switzerland), among others. An analysis of the market developments between 2016 and 2019 revealed that product launches & enhancements, partnerships, agreements, and acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the market. Product launches were the most widely adopted growth strategies.

Sysmex (Japan) held the leading position in the global hematology analyzers and reagents market. The company is an integrated supplier of instruments and reagents in the field of diagnostics. It focuses on both organic and inorganic growth methods such as expansions, agreements, and new product launches to ensure its growth in the hematology analyzers and reagents market. In line with this, over the last three years, the company launched XN-9100, XN-3100, XN-1500, XN-L, and SP-50 (an automated hematology slide preparation unit). Additionally, the company has improved its sales and support networks in emerging markets, due to which it maintains its leading position in the hematology analyzers and reagents market. Therefore, the heavy investments in developing better and technologically superior products are fueling the company’s market growth in the industry.

This report categorizes the global hematology analyzers and reagents market into the following segments and subsegments:

Global Hematology Analyzers and Reagents Market, by Product & Service

• Hematology Products & Services
  • Instruments
    • 5-part and 6-part Fully Automated Hematology Analyzers
    • 3-part Fully Automated Hematology Analyzers
    • Point-of-care Testing Hematology Analyzers
    • Semi-automated Hematology Analyzers
  • Reagents & Consumables
    • Hematology Reagents
    • Slide Stainers/Makers
    • Controls and Calibrators
    • Consumables
  • Services
    • Hemostasis Products & Services
  • Instruments
  • Reagents & Consumables
  • Services
    • Immunohematology Products & Services
  • Instruments
  • Reagents & Consumables
  • Services

Hematology Instruments Market, by Price range

• High-end Hematology Analyzers
• Mid-range Hematology Analyzers
• Low-end Hematology Analyzers

Hematology Products & Services Market, by End User

• Hospital Laboratories
• Commercial Service Providers 
• Government Reference Laboratories
• Research & Academic Institutes

Hematology Products & Services Market, by Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Rest of Europe (RoE)
• Asia Pacific
  • Japan
  • China
  • India
  • Rest of Asia Pacific (RoAPAC)
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America (RoLATAM)
• Middle East & Africa